Identification of phytocompounds from Paris polyphylla Smith as potential inhibitors for HER2 & VEGFR2 cancer genes using molecular docking and molecular dynamics simulation studies

被引:0
|
作者
Das Gupta D. [1 ]
Mahanta S. [2 ]
Ullah T.N. [1 ]
Das S.K. [1 ]
Bellai A. [1 ]
Tag H. [3 ]
Hui P.K. [1 ]
机构
[1] Department of Biotechnology, National Institute of Technology (NIT)-Arunachal Pradesh, Jote, Arunachal Pradesh, Papum Pare
[2] National Institute of Electronics and Information Technology, Assam, Guwahati
[3] Plant Systematics and Ethnobotanical Research Laboratory, Department of Botany, Rajiv Gandhi University, Rono Hills, Arunachal Pradesh, Doimukh
来源
Vegetos | 2024年 / 37卷 / 6期
关键词
Catechin; HER2/VEGFR2; MD simulations; Molecular docking; Paris polyphylla; Quercetin;
D O I
10.1007/s42535-023-00754-7
中图分类号
学科分类号
摘要
In the present studies, molecular docking and molecular dynamic simulation analyses were done to identify phytocompounds from Paris polyphylla as potential inhibitors for HER2 and VEGFR2. The 10 top-hit phytocompounds were docked using the SP docking algorithm of the Schrödinger Suite’s Glide module (SSGM) 2020–2023 against binding pockets of HER2 and VEGFR2 and applied for extra precision (XP) docking in SSGM 2020–2023. Present studies revealed phytocompound (ligand) catechin (PP37) to have a strong binding affinity towards the receptor HER2 (PDB ID: 3PP0) with a docking score and Glide g score (G-Score) of − 9.194, and also quercetin (PP32) which demonstrated a good binding affinity with receptor VEGFR2 (PDB ID: 4AGC) with docking score and Glide g score (G-Score) of − 7.865. In Molecular dynamics (MD) simulation analysis, the ligand-receptor complex [catechin (PP37) and HER2 (PDB ID: 3PP0)] showed deviation during the first 10 ns but showed stability up to 100 ns while the Quercetin (PP32) and VEGFR2 (PDB ID: 4AGC)] complex showed stability during initial 10–50 ns and were found slightly unstable up to 100 ns. Both catechin (PP37) and quercetin (PP32) have passed all the drug discovery rules in ADME-Tox analysis. This study confirmed catechin and quercetin from P. polyphylla as potential inhibitors for HER2 and VEGFR2 cancer oncoproteins. © 2023, The Author(s) under exclusive licence to Society for Plant Research.
引用
收藏
页码:2542 / 2556
页数:14
相关论文
共 50 条
  • [41] Benzylpyrazolyl naphthoquinones as potential VEGFR-2, GPCR and PPAR inhibitors: Synthesis, anti-cancer evaluation, molecular docking and DFT studies
    Patil, Pradnya
    Patil, Pruthanka
    Dandge, Padma
    Bansode, Prakash
    Kumbhar, Bajarang
    Chandane, Wilson
    Rathod, Sanket
    Choudhari, Prafulla
    Khot, Suraj
    Valekar, Navanath
    Pore, Dattaprasad
    Rashinkar, Gajanan
    JOURNAL OF MOLECULAR STRUCTURE, 2024, 1301
  • [42] IDENTIFICATION OF NOVEL COUMARIN BASED COMPOUNDS AS POTENTIAL INHIBITORS OF THE 3-CHYMOTRYPSIN-LIKE MAIN PROTEASE OF SARS-COV-2 USING DFT, MOLECULAR DOCKING AND MOLECULAR DYNAMICS SIMULATION STUDIES
    MORAN, G. SALGADO.
    CARDONA, W. I. L. S. O. N., V
    CANDIA, LORENA. G. E. R. L. I.
    MENDOZA-HUIZAR, L. H.
    ABDIZADEH, T. O. O. B. A.
    JOURNAL OF THE CHILEAN CHEMICAL SOCIETY, 2022, 67 (02): : 5521 - 5536
  • [43] Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies
    Bilal, Muhammad Sajjad
    Ejaz, Syeda Abida
    Zargar, Seema
    Akhtar, Naveed
    Wani, Tanveer A.
    Riaz, Naheed
    Aborode, Adullahi Tunde
    Siddique, Farhan
    Altwaijry, Nojood
    Alkahtani, Hamad M.
    Umar, Haruna Isiyaku
    BIOMOLECULES, 2022, 12 (11)
  • [44] Benzylpyrazolyl naphthoquinones as potential VEGFR-2, GPCR and PPAR inhibitors: Synthesis, anti-cancer evaluation, molecular docking and DFT studies
    Patil, Pradnya
    Patil, Pruthanka
    Dandge, Padma
    Bansode, Prakash
    Kumbhar, Bajarang
    Chandane, Wilson
    Rathod, Sanket
    Choudhari, Prafulla
    Khot, Suraj
    Valekar, Navanath
    Pore, Dattaprasad
    Rashinkar, Gajanan
    Journal of Molecular Structure, 2024, 1301
  • [45] In silico Molecular Modelling and Docking Studies on Kinase Inhibitors as Potential Anti-Cancer Target in HER2-associated Breast Cancer
    Gupta, Binni
    Tiwari, Apoorv
    Taj, Gohar
    Pal, Neeraj
    Malik, Rashmi
    Kumar, Sundip
    LETTERS IN ORGANIC CHEMISTRY, 2023, 20 (04) : 300 - 311
  • [46] Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies
    Fouad, Marwa A.
    Osman, Alaa A.
    Abdelhamid, Noha M.
    Rashad, Mai W.
    Nabawy, Ashrakat Y.
    El Kerdawy, Ahmed M.
    BMC CHEMISTRY, 2024, 18 (01)
  • [47] Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies
    Marwa A. Fouad
    Alaa A. Osman
    Noha M. Abdelhamid
    Mai W. Rashad
    Ashrakat Y. Nabawy
    Ahmed M. El Kerdawy
    BMC Chemistry, 18
  • [48] Molecular Docking and Dynamics Simulation Studies Predict Potential Anti-ADAR2 Inhibitors: Implications for the Treatment of Cancer, Neurological, Immunological and Infectious Diseases
    Broni, Emmanuel
    Striegel, Andrew
    Ashley, Carolyn
    Sakyi, Patrick O.
    Peracha, Saqib
    Velazquez, Miriam
    Bebla, Kristeen
    Sodhi, Monsheel
    Kwofie, Samuel K.
    Ademokunwa, Adesanya
    Khan, Sufia
    Miller III, Whelton A. A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [49] Pharmacophore screening, molecular docking, and MD simulations for identification of VEGFR-2 and c-Met potential dual inhibitors
    Dong, Junmin
    Hao, Xiaohua
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [50] In Silico Repurposing of a Novel Inhibitor (drug) of EGFR and VEGFR-2 Kinases of Cancer by Pharmacokinetics, Toxicity, Molecular Docking, and Molecular Dynamics Simulation
    Ibraheim, Mona H.
    Maher, Ibrahim
    Khater, Ibrahim
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2024, 196 (11) : 8332 - 8365